Clinical Pharmacology & Therapeutics · 2015 · 26 citations · 3 references
MedicineMolecular GeneticsOncologyGenomicsMolecular OncologyTumor HeterogeneityCancer GenomicsMalignant NeoplasmsPersonalized Cancer TherapyGenomic Alteration ProfilingPersonalized Cancer MedicineTumor Profiling
Early-phase clinical development in oncology has evolved dramatically with the deciphering of the human genome in 2004. Genomic analysis and the tools identifying genetically disrupted pathways within a patient's tumor have been a driving force for personalized medicine and for the development of highly targeted novel therapies. Tumors are often genetically heterogeneous, with multiple concurrent genetic abnormalities. On the other hand, tumors arising from different tissues may share identical molecular drivers.
3
Benchmarking the Study Initiation Process
Mary Jo Lamberti, Cindy Brothers, Dan Manak et al. · Therapeutic Innovation & Regulatory Science · 2013 · 17 citations